Liaised between AI research and oncology teams, managing 10+ cross-functional projects to translate state-of-the-art deep learning methods into biomarker and drug development applications.
Drove publication and conference strategy, co-authoring and structuring four manuscripts on novel model development published in Cancer Cell, Nature Communications, and NPJ Precision Medicine, and a fifth submitted to Cancer Cell (under review) β all within one year.
Led company-wide AI upskilling initiatives, including a weekly seminar series (~120 attendees) hosting speakers from academic labs and startups working at the intersection of AI and biomedicine.
Partnered with corporate communications, media relations, and internal communications to align ongoing AI research with broader R&D initiatives.